Biokraft Foods Hosts ‘What We Eat, What We Become’ Panel Discussion in the Run-Up to Mumbai Climate Week
Food, biodiversity, and climate voices come together at Mumbai Climate Week through an event hosted by Biokraft Foods in collaboration with Project MumbaiMUMBAI,…
BioAro Secures UAE Approval for AI-Enabled Longevity Bioactives, Setting the Stage for Global Expansion
DUBAI, United Arab Emirates and TORONTO, Feb. 10, 2026 (GLOBE NEWSWIRE) --…
Ipsen – January 2026 – Monthly information relative to the total number of voting rights and shares composing the share capital
Monthly information relative to the total number of voting rights and shares…
AB Science announced that the Food and Drug Administration (FDA) granted the status of Minor Use in Major Species (MUMS) for Masivet in the treatment of canine mast cell tumors
PRESS RELEASE AB SCIENCE ANNOUNCES THAT THE FDA HAS GRANTED THE STATUS…
DAR GLOBAL DEBUTS NICKELODEON HOTELS & RESORTS OMAN IN AIDA, THE ICONIC BRAND OF FAMILY ENTERTAINMENT
MUSCAT, Sultanate of Oman, Feb. 9, 2026 /PRNewswire/ -- Dar Global, the…
Space Summit 2026 Concludes in Singapore with Focus on Alignment Across the Global Space Ecosystem
SINGAPORE, Feb. 9, 2026 /PRNewswire/ -- Organised by Experia Events Pte Ltd,…
‘Made in India – The story of Desh Bandhu Gupta, Lupin and Indian Pharma’ Book Launched in Mumbai
MUMBAI, India, Feb. 9, 2026 /PRNewswire/ -- Made in India, written by…
Joveos 2026 Recruiting Benchmarks Report Reveals Up to 9x Growth in Applicant Volume Over the Past Three Years
MENLO PARK, Calif., Feb. 06, 2026 (GLOBE NEWSWIRE) -- Joveo, the global…
The Ministry of Finance and the International Monetary Fund to launch tomorrow the second edition of the AlUla Conference for Emerging Market Economies
AlUla, Saudi Arabia, Feb. 7, 2026 /PRNewswire/ -- The second edition of…
Roches fenebrutinib is the first investigational medicine in over a decade that reduces disability progression in primary progressive multiple sclerosis (PPMS)
Late-breaking Phase III FENtrepid results presented at ACTRIMS show investigational fenebrutinib met…
